Simple blood draw. Accurately diagnose.
Identify potential arterial injury due to inflammation.
SmartVascular Dx™ accurately diagnoses clinically significant vascular inflammation associated with clinical conditions such as infections, autoimmune diseases, cancer, COVID-19, and metabolic abnormalities, all of which have an increased risk of heart attack and stroke.
SmartVascular Dx Test Benefits
Measures
- 7 protein biomarkers to identify arterial injury (CTACK, Eotaxin, Fas Ligand, HGF, IL-16, MCP-3 and sFas)
Determines
- Endothelial Inflammation
- Identifies soft lesion or stroke risk undetected today by other blood tests
Health Advantages
- Clear and accurate reporting of current overall health status from endothelial damage caused by inflammation.
- Easy-to-read physician report showing results at a glance with current health and serial reporting for multi-year tracking.
- Ability to request the test annually to stay on track with health monitoring.
- Independent validation with multiple patient ethnicities.
About SmartVascular Dx
SmartVascular Dx has been developed through a series of longitudinal outcome-based studies with multiple institutions over a 15-year period of collaborative research representing over 40,000 patients. Our test has been independently validated at the National Institute of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) in the Multi-Ethnic Study of Atherosclerosis (MESA).
